ClearMind Biomedical Clears FIM Clinical Trial for Least Invasive ICH Treatment to Date
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Stay updated with breaking news from Carrey Yang. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from PR Newswire. The AP news staff was not involved in its creation.
ClearMind Biomedical's Axonpen Neuroendoscope Receives 510K Clearance News provided by Share this article Share this article LOS ANGELES, Jan. 11, 2021 /PRNewswire/ -- ClearMind Biomedical has received FDA clearance for its novel neuroendoscope, the Axonpen System, for illumination and visualization of intracranial tissue and fluids, and the controlled aspiration of tissue and/or fluid during surgery. First in man clinical trial in operation. Requiring only a narrow channel of 6.5mm through the skull for insertion into the brain, the steerable Axonpen combines excellent tissue visualization...